Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Breast Cancer Research and Treatment|July 6, 2013
Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy responseE H Lips, L Mulder, J J de Ronde, et al.
Breast Cancer Research and Treatment|December 20, 2017
Enrichment of high-grade tumors in breast cancer gene expression studiesM van Seijen, A L Mooyaart, L Mulder, et al.
British Journal of Cancer|April 6, 2013
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriersE H Lips, L Mulder, A Oonk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2010
Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapyE H Lips, L Mulder, J Hannemann, et al.
Breast Cancer Research and Treatment|April 8, 2011
Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristicsE H Lips, L Mulder, J J de Ronde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapyA M M Oonk, C van Rijn, M M Smits, et al.
Breast Cancer Research and Treatment|July 27, 2015
The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measureM Jebbink, E van Werkhoven, I A M Mandjes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2012
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapyB B Koolen, M J T F D Vrancken Peeters, J Wesseling, et al.
NPJ Breast Cancer|April 18, 2024
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockadeM C Liefaard, A van der Voort, M van Seijen, et al.
The Journal of Pathology|May 2, 2007
Single nucleotide polymorphism array analysis of chromosomal instability patterns discriminates rectal adenomas from carcinomasE H Lips, E J de Graaf, R A E M Tollenaar, et al.
Pageof 2